Loading clinical trials...
Loading clinical trials...
Phase II Study of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
Conditions
Interventions
Gemcitabine and Cisplatin
Locations
9
United States
Mayo Clinic - Arizona
Scottsdale, Arizona, United States
Hartford Hospital (Data Collection Only)
Hartford, Connecticut, United States
Memorial Sloan Kettering at Basking Ridge
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Bergen
Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center @ Suffolk
Commack, New York, United States
Memorial Sloan Kettering Westchester
Harrison, New York, United States
Start Date
December 14, 2010
Primary Completion Date
August 6, 2025
Completion Date
August 6, 2025
Last Updated
August 8, 2025
NCT07061964
NCT05987241
NCT06349642
NCT07452432
NCT06668493
NCT06809140
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions